Lab-Grown Pituitary Organoids Restored Hormone Levels
Researchers successfully transplanted human organoids into a macaque to produce essential hormones.
Updated on Oct. 14, 2026 in Diabetes
Live Poll
Would you trust lab-grown organoid tissue to replace your need for daily hormone medications?
Scientists have successfully used lab-grown human pituitary organoids to restore hormone production in a macaque. This advancement offers a potential path for future treatments for individuals with hypopituitarism, a condition that currently affects roughly 45 in every 100,000 people.
Why it matters
The development aims to provide a reliable source of hormone-producing tissue that could eventually eliminate the need for lifelong hormone replacement therapy. This addresses a significant clinical challenge for patients who require constant medication to manage adrenal function.
In this preclinical research, scientists transplanted 1,440 human pituitary organoids into a 15-year-old macaque, alongside studies in 17 immune-deficient mice. While mice showed improved survival, the macaque required immune-suppressing drugs to prevent transplant rejection.
The players
Nagoya University
A Japanese research institution that led the development of the human pituitary organoids.
Shiga University of Medical Science
An academic medical center that hosted the transplant procedure performed on the macaque.
The details
The researchers created the organoids from human embryonic stem cells, specifically engineering them to contain ACTH-producing cells and hypothalamus tissue. The team successfully implanted this tissue into fat on the macaque's back, where it began to signal the adrenal glands to produce cortisol. Although the tissue functioned initially, immune rejection remains a significant barrier that researchers must overcome to improve durability.
Timeline
Six days post-transplant, the macaque stopped receiving cortisol pills.
Six weeks post-transplant, data collection ended due to the monkey's health.
Three months post-transplant, researchers identified living ACTH cells in the macaque.
Six months post-transplant, transplanted mice showed measurable blood ACTH levels.
Health Landscape
The study marks an early experimental milestone within the development of clinical-grade stem cell tissue, a field currently focused on scaling production and improving graft survival. This approach represents a significant departure from current standards, which rely on lifelong hormone replacement pills.
This research is currently in the experimental stage and does not offer a clinical treatment option today. Individuals managing hormone deficiencies like hypopituitarism should continue to follow their current prescribed hormone replacement regimen and discuss any new research developments with their physician.
The takeaway
The successful transplantation of pituitary tissue in an animal model provides a proof-of-concept for replacing lost endocrine function. Patients should continue to monitor their hormone levels regularly with their endocrinologist as researchers work toward more permanent tissue integration methods.
Further reading
For more on managing endocrine conditions, visit our Diabetes section.
Source note: This article includes information reported by Earth.
Live Poll
Would you trust lab-grown organoid tissue to replace your need for daily hormone medications?
